Pasar al contenido principal

APROXIMACIONES BASADAS EN REDES PARA ASISTIR AL DIAGNOSTICO DE ENFERMEDADES RARAS BASADO EN ASOCIACIONES GENOTIPO-FENOTIPO

PID2019-108096RB-C22

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Phenotype-genotype comorbidity analysis of patients with rare disorders provides insight into their pathological and molecular bases

  • Díaz-Santiago, Elena
  • Jabato, Fernando M.
  • Rojano, Elena
  • Seoane, Pedro
  • Pazos, Florencio
  • Perkins, James R.
  • Ranea, Juan A. G.
© 2020 Díaz-Santiago et al., Genetic and molecular analysis of rare disease is made difficult by the small numbers of affected patients. Phenotypic comorbidity analysis can help rectify this by combining information from individuals with similar phenotypes and looking for overlap in terms of shared genes and underlying functional systems. However, few studies have combined comorbidity analysis with genomic data. We present a computational approach that connects patient phenotypes based on phenotypic co-occurence and uses genomic information related to the patient mutations to assign genes to the phenotypes, which are used to detect enriched functional systems. These phenotypes are clustered using network analysis to obtain functionally coherent phenotype clusters. We applied the approach to the DECIPHER database, containing phenotypic and genomic information for thousands of patients with heterogeneous rare disorders and copy number variants. Validity was demonstrated through overlap with known diseases, co-mention within the biomedical literature, semantic similarity measures, and patient cluster membership. These connected pairs formed multiple phenotype clusters, showing functional coherence, and mapped to genes and systems involved in similar pathological processes. Examples include claudin genes from the 22q11 genomic region associated with a cluster of phenotypes related to DiGeorge syndrome and genes related to the GO term anterior/posterior pattern specification associated with abnormal development. The clusters generated can help with the diagnosis of rare diseases, by suggesting additional phenotypes for a given patient and potential underlying functional systems. Other tools to find causal genes based on phenotype were also investigated. The approach has been implemented as a workflow, named PhenCo, which can be adapted to any set of patients for which phenomic and genomic data is available. Full details of the analysis, including the clusters formed, their constituent functional systems and underlying genes are given. Code to implement the workflow is available from GitHub., The study was funded by grants from the The Spanish Ministry of Science and Innovation with European Regional Development Fund [PID2019-108096RB-C21 to J.A.G and PID2019- 108096RB-C22 to F.P.]; the Andalusian Government (Junta de Andalucia) with European Regional Development Fund [UMA18-FEDERJA102], and Biomedicine Research project [PI-0075- 2017] (Fundacion Progreso y Salud); and the Ramo´n Areces foundation, which funds project for the investigation of rare disease (National call for research on life and material sciences, XIX edition); Ramo´n y Cajal I3 projects through the Research Plan of the University of Malaga (Ayudas del I Plan Propio). The CIBERER is an initiative from the Carlos III Health Institute (Instituto de Salud Carlos III; ISCIII).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CoMentG: comprehensive retrieval of generic relationships between biomedical concepts from the scientific literature

  • Novoa, Jorge
  • López-Ibáñez, Javier
  • Chagoyen, Mónica
  • Ranea, Juan A. G.
  • Pazos, Florencio
The CoMentG resource contains millions of relationships between terms of biomedical interest obtained from the scientific literature. At the core of the system is a methodology for detecting significant co-mentions of concepts in the entire PubMed corpus. That method was applied to nine sets of terms covering the most important classes of biomedical concepts: diseases, symptoms/clinical signs, molecular functions, biological processes, cellular compartments, anatomic parts, cell types, bacteria and chemical compounds. We obtained more than 7 million relationships between more than 74 000 terms, and many types of relationships were not available in any other resource. As the terms were obtained from widely used resources and ontologies, the relationships are given using the standard identifiers provided by them and hence can be linked to other data. A web interface allows users to browse these associations, searching for relationships for a set of terms of interests provided as input, such as between a disease and their associated symptoms, underlying molecular processes or affected tissues. The results are presented in an interactive interface where the user can explore the reported relationships in different ways and follow links to other resources. Database URL: https://csbg.cnb.csic.es/CoMentG/., Spanish Ministry of Economy and Competitiveness with European Regional Development Fund (grant numbers PID2019-108096RB-C21 and PID2022-140047OB-C21 to J.A.G.R., PID2019-108096RB-C22 and PID2022-1400 47OB-C22 to F.P.); The Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019), co-funded by the European Union, European Regional Development Fund (‘A way to make Europe’); The European Food Safety Authority (grant number GP/EFSA/ENCO/2020/02 to F.P.); and the European Union (grant number HORIZON-HLTH-2022-DISEASE-06, Project ID: 101080580 to J.A.G.R.). The conclusions, findings and opinions expressed in this scientific paper reflect only the view of the authors and not the official position of the Euro- pean Food Safety Authority. CIBERER is an initiative from the Institute of Health Carlos III., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

MBROLE3: improved functional enrichment of chemical compounds for metabolomics data analysis

  • López-Ibáñez, Javier
  • Pazos, Florencio
  • Chagoyen, Mónica
MBROLE (Metabolites Biological Role) facilitates the biological interpretation of metabolomics experiments. It performs enrichment analysis of a set of chemical compounds through statistical analysis of annotations from several databases. The original MBROLE server was released in 2011 and, since then, different groups worldwide have used it to analyze metabolomics experiments from a variety of organisms. Here we present the latest version of the system, MBROLE3, accessible at http://csbg.cnb.csic.es/mbrole3. This new version contains updated annotations from previously included databases as well as a wide variety of new functional annotations, such as additional pathway databases and Gene Ontology terms. Of special relevance is the inclusion of a new category of annotations, 'indirect annotations', extracted from the scientific literature and from curated chemical-protein associations. The latter allows to analyze enriched annotations of the proteins known to interact with the set of chemical compounds of interest. Results are provided in the form of interactive tables, formatted data to download, and graphical plots., Spanish Ministry of Economy and Competitiveness with European Regional Development Fund [PID2019-108096RB-C22 to F.P. and M.C.]; Spanish State Research Agency [AEI/10.13039/501100011033] through the ‘Severo Ochoa’ Programme for Centres of Excellence in R&D [SEV-2017-0712]; European Food Safety Authority [GP/EFSA/ENCO/2020/02 to F.P.]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Differential expression and co-expression reveal cell types relevant to genetic disorder phenotypes

  • Alías-Segura, Sergio
  • Pazos, Florencio
  • Chagoyen, Mónica
Knowledge of the specific cell types affected by genetic alterations in rare diseases is crucial for advancing diagnostics and treatments. Despite significant progress, the cell types involved in the majority of rare disease manifestations remain largely unknown. In this study, we integrated scRNA-seq data from non-diseased samples with known genetic disorder genes and phenotypic information to predict the specific cell types disrupted by pathogenic mutations for 482 disease phenotypes., This work was supported by the Spanish Ministry of Economy and Competitiveness with the European Regional Development Fund [grant numbers PID2019-108096RB-C22 and PID2022-140047OB-C22] to M.C. and F.P., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Disentangling protein metabolic costs in human cells and tissues.

  • Chagoyen, Mónica
  • Poyatos, Juan F.
Many intrinsic functional characteristics of cells and tissues shape their genome-wide expression patterns. But what other factors might also modulate these patterns are not fully known. Here, we revisit the general model of costs in which the protein products of highly expressed genes should be short and made up of biosynthetically cheap amino acids. We first use single-cell expression data from a collection of human cell types to confirm this model with a twist: the most highly expressed proteins tend to be particularly short and use expensive amino acids. By clustering how these two factors change with expression across all cell types, we identified a set of archetypal profiles that uniquely balance costs and that occur at different proportion across cell types. Similar profiles were also found by examining the expression data of tissues, which allowed us to recognize those following a more or less costly strategy. We then asked how this model might delineate the expression changes seen in a tumor relative to its normal solid tissue, as it has been argued that energy constraints determine cancer progression. We discovered a strong signal for the overexpression of biosynthetically cheap compact genes in cancer tissues. Our work highlights how both aspects of the metabolic cost of a protein, length and amino acid biosynthesis, represent valuable measures for understanding the different levels of biological organization and also the differences between health and disease., This work was supported by grant PID2019-108096RB-C22 (MC) and PID2019-106116RB-I00 (JFP) from the Spanish Ministry of Economy and Competitiveness with European Regional Development Fund, No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Disentangling protein metabolic costs in human cells and tissues

  • Chagoyen, Mónica
  • Poyatos, Juan F.
Supplementary material is available at PNAS Nexus online, While more data are becoming available on gene activity at different levels of biological organization, our understanding of the underlying biology remains incomplete. Here, we introduce a metabolic efficiency framework that considers highly expressed proteins (HEPs), their length, and biosynthetic costs in terms of the amino acids (AAs) they contain to address the observed balance of expression costs in cells, tissues, and cancer transformation. Notably, the combined set of HEPs in either cells or tissues shows an abundance of large and costly proteins, yet tissues compensate this with short HEPs comprised of economical AAs, indicating a stronger tendency toward mitigating costs. We additionally observe that short proteins are prevalent HEPs across individual cells and tissues, whereas long ones are more specific. Furthermore, the precise proportion of short, long, economical, or costly HEP classes indicates that particular cell types and tissues align more closely with the metabolic efficiency model, with some tissues displaying behavior akin to their constituent cells. Finally, tumors typically increase the production of short and low-cost HEPs compared with matched normal tissues, while genes that decrease their high expression levels in tumors often tend to be associated with high costs. Overall, the metabolic efficiency framework serves as a useful simplifying model for interpreting genome-wide expression data across scales., This work was supported by grants PID2019-108096RB-C22 (M.C.), PID2019-106116RB-I00 (J.F.P.), and PID2023-151289NB-I00 (J.F.P.) funded by Ministerio de Ciencia, Innovaci\u00F3n y Universidades MICIU/AEI/10.13039/501100011033 and by \u201CERDF/EU\u201D., Peer reviewed